Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA)...

por Matthews, David R., Inzucchi, Silvio E.
Publicado 2012

Mysterious Hyperglycemia: Disease Versus Device

por Inzucchi, Silvio E., Spollett, Geralyn R.
Publicado 2017

Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin

por Fonseca, Vivian, Inzucchi, Silvio E., Ferrannini, Ele
Publicado 2009

A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease

por Ahmad, Tariq, Riello, Ralph J, Inzucchi, Silvio E
Publicado 2021

Primary hypothyroidism presenting as neuropsychiatric symptoms and pituitary enlargement in a young woman: illustrative case

por Haider, Shanzay, Templeton, Kelsey, Omay, S. Bulent, Inzucchi, Silvio E.
Publicado 2023

Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

por Lipska, Kasia J., Bailey, Clifford J., Inzucchi, Silvio E.
Publicado 2011

Minimization of Hypoglycemia as an Adverse Event During Insulin Infusion: Further Refinement of the Yale Protocol

por Marvin, Michael R., Inzucchi, Silvio E., Besterman, Brian J.
Publicado 2016

Extreme High Insulin Requirements in Two Non-Diabetic Patients Following Cardiac Transplantation

por Balasubramanian, Priyadarshini, Moreau, Christi, Ahmad, Tariq, Inzucchi, Silvio E
Publicado 2021

Acute Myeloid Leukemia Leading to Central Diabetes Insipidus

por Wojeck, Brian, Gossmann, Mona, Zeidan, Amer, Inzucchi, Silvio E
Publicado 2021

Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action

por Draznin, Boris, Gilden, Janice, Golden, Sherita H., Inzucchi, Silvio E.
Publicado 2013

SAT-258 Surprising Transformation of a Microprolactinoma to a Macroprolactinoma

por Athonvarangkul, Diana, Hosier, Hillary Wyeth, Wojeck, Brian, Inzucchi, Silvio E
Publicado 2020

Improved extremity tissue oxygenation with short-term exposure to textiles embedded with far infrared light emitting thermoactive particles in patients with diabetes mellitus

por Athonvarangkul, Diana, Wang, Kaicheng, Deng, Yanhong, Inzucchi, Silvio E, Mayerson, Adam
Publicado 2023

Bladder cancer in the EMPA-REG OUTCOME trial

por Kohler, Sven, Lee, Jisoo, George, Jyothis T., Inzucchi, Silvio E., Zinman, Bernard
Publicado 2017

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes

por Rosenstock, Julio, Inzucchi, Silvio E., Seufert, Jochen, Fleck, Penny R., Wilson, Craig A., Mekki, Qais
Publicado 2010

Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S52–S...

por Herman, William H., Kalyani, Rita R., Wexler, Deborah J., Matthews, David R., Inzucchi, Silvio E.
Publicado 2016

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG...

por Verma, Subodh, Mazer, C. David, Fitchett, David, Inzucchi, Silvio E., Pfarr, Egon, George, Jyothis T., Zinman, Bernard
Publicado 2018

Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits

por McGuire, Darren K., Inzucchi, Silvio E., Johansen, Odd Erik, Rosenstock, Julio, George, Jyothis T., Marx, Nikolaus
Publicado 2021

Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME...

por Neeland, Ian J., Kasai, Takatoshi, Inzucchi, Silvio E., Wojeck, Brian S., Yaggi, Henry K., Johansen, Odd Erik
Publicado 2021

Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA‐REG OUTCOME trial

por Ferreira, João Pedro, Inzucchi, Silvio E., Mattheus, Michaela, Meinicke, Thomas, Steubl, Dominik, Wanner, Christoph, Zinman, Bernard
Publicado 2021

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

por Fouqueray, Pascale, Pirags, Valdis, Inzucchi, Silvio E., Bailey, Clifford J., Schernthaner, Guntram, Diamant, Michaela, Lebovitz, Harold E.
Publicado 2013